Trial Profile

Combination of Antihypertensive therapy in the elderly, Multicenter Investigation Multi-center randomized controlled study on efficacy of ARB/Diuretic mixture versus ARB/Ca channel blocker combination therapy to blood pressure or cognitive function in the elderly patients who have insufficient controlled hypertension in ARB monotherapy

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 13 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Losartan/hydrochlorothiazide (Primary) ; Amlodipine; Angiotensin receptor antagonists
Indications Essential hypertension
Focus Therapeutic Use
Acronyms CAMUI

17 Jun 2013 Results assessing renal function presented at the 23rd European Meeting on Hypertension.
04 Oct 2012 Status changed from active, no longer recruiting to completed.
04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com